SeromYx at a glance:

  • Formed in July 2019 to commercialize the Systems Serology platform developed by Dr. Galit Alter at the Ragon Institute of Harvard/MIT/MGH, with the support of DARPA and the Bill and Melinda Gates Foundation
  • Our Mission: Use our proprietary tools to provide our clients with unprecedented insight into immune function so that they can discover and develop better vaccines, immunotherapies, drugs, and diagnostics
  • Fee for service business model; no entanglement of client IP.

Learn about our ongoing work to support responses to the SARS-CoV-2 pandemic.

updated: 10 months ago